MCM
RPRX icon

Manchester Capital Management’s Royalty Pharma RPRX Stock Holding History

Manchester Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.2K Hold
587
– – ﹤0.01% 608
2025
Q4 		$22.7K Buy
587
+39
+7% +$1.49K ﹤0.01% 636
2025
Q3 		$19.3K Sell
548
-20
-4% -$724 ﹤0.01% 748
2025
Q2 		$20.5K Sell
568
-15
-3% -$497 ﹤0.01% 714
2025
Q1 		$18.1K Buy
583
+175
+43% +$5.55K ﹤0.01% 728
2024
Q4 		$10.4K Buy
+408
New +$10.8K ﹤0.01% 801
2022
Q1 		– Sell
-238
Closed -$9K – 1090
2021
Q4 		$9K Buy
+238
New +$9.25K ﹤0.01% 579
2021
Q1 		– Sell
-33
Closed -$2K – 764
2020
Q4 		$2K Buy
+33
New +$1.4K ﹤0.01% 620

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return